Enhancing Rehabilitative Therapies with Vagus Nerve Stimulation
Neurotherapeutics, ISSN: 1878-7479, Vol: 13, Issue: 2, Page: 382-394
2016
- 82Citations
- 267Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations82
- Citation Indexes80
- 80
- CrossRef75
- Patent Family Citations1
- 1
- Policy Citations1
- 1
- Captures267
- Readers267
- 267
- Mentions1
- News Mentions1
- 1
Most Recent News
Transcutaneous Vagus Nerve Stimulation (tVNS) and Robotic Training to Improve Arm Function After Stroke; tVNS
STUDY INFORMATION OFFICIAL TITLE: Evaluating the Use of Transcutaneous Vagus Nerve Stimulation (tVNS) and Robotic Training to Improve Upper Limb Motor Recovery After Stroke CURRENT
Review Description
Pathological neural activity could be treated by directing specific plasticity to renormalize circuits and restore function. Rehabilitative therapies aim to promote adaptive circuit changes after neurological disease or injury, but insufficient or maladaptive plasticity often prevents a full recovery. The development of adjunctive strategies that broadly support plasticity to facilitate the benefits of rehabilitative interventions has the potential to improve treatment of a wide range of neurological disorders. Recently, stimulation of the vagus nerve in conjunction with rehabilitation has emerged as one such potential targeted plasticity therapy. Vagus nerve stimulation (VNS) drives activation of neuromodulatory nuclei that are associated with plasticity, including the cholinergic basal forebrain and the noradrenergic locus coeruleus. Repeatedly pairing brief bursts of VNS sensory or motor events drives robust, event-specific plasticity in neural circuits. Animal models of chronic tinnitus, ischemic stroke, intracerebral hemorrhage, traumatic brain injury, and post-traumatic stress disorder benefit from delivery of VNS paired with successful trials during rehabilitative training. Moreover, mounting evidence from pilot clinical trials provides an initial indication that VNS-based targeted plasticity therapies may be effective in patients with neurological diseases and injuries. Here, I provide a discussion of the current uses and potential future applications of VNS-based targeted plasticity therapies in animal models and patients, and outline challenges for clinical implementation.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1878747923015933; http://dx.doi.org/10.1007/s13311-015-0417-z; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84949974474&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/26671658; https://linkinghub.elsevier.com/retrieve/pii/S1878747923015933; https://dx.doi.org/10.1007/s13311-015-0417-z; http://link.springer.com/article/10.1007/s13311-015-0417-z/fulltext.html; https://link.springer.com/article/10.1007/s13311-015-0417-z; https://link.springer.com/content/pdf/10.1007%2Fs13311-015-0417-z.pdf; http://link.springer.com/10.1007/s13311-015-0417-z; http://link.springer.com/article/10.1007%2Fs13311-015-0417-z
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know